Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
BMC Infectious Diseases|January 3, 2025
Unusual presentation of esophageal tuberculosis: a case studyMing Xue, Yue-Can Zeng
Critical Reviews in Oncology/Hematology|November 20, 2021
Pseudoprogression in lung cancer patients treated with immunotherapyMeng-Yu Chen, Yue-Can Zeng
Frontiers in Cell and Developmental Biology|July 5, 2022
Chemotherapy- and Immune-Related Gene Panel in Prognosis Prediction and Immune Microenvironment of SCLCMeng-Yu Chen, Yue-Can Zeng, Xi-He Zhao
Translational Oncology|October 16, 2020
Combination therapy: Future directions of immunotherapy in small cell lung cancerWei Huang, Jia-Jia Chen, Rui Xing, et al.
Molecular Biology Reports|December 28, 2012
Circulation insulin-like growth factor peptides and colorectal cancer risk: an updated systematic review and meta-analysisFeng Chi, Rong Wu, Yue-can Zeng, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 28, 2017
Gankyrin promotes the proliferation of gastric cancer and is associated with chemosensitivityYue-Can Zeng, Dan Sun, Wen-Hui Li, et al.
Cellular Oncology (Dordrecht, Netherlands)|June 2, 2017
MDMX is a prognostic factor for non-small cell lung cancer and regulates its sensitivity to cisplatinHan Zhao, Yu-Zhuo Xie, Rui Xing, et al.
Surgical Oncology|August 28, 2016
RBX1 expression is an unfavorable prognostic factor in patients with non-small cell lung cancerRui Xing, Kuan-Bing Chen, Ying Xuan, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|June 4, 2013
Post-diagnosis soy food intake and breast cancer survival: a meta-analysis of cohort studiesFeng Chi, Rong Wu, Yue-Can Zeng, et al.
American Journal of Translational Research|May 18, 2016
Sestrin2 expression is a favorable prognostic factor in patients with non-small cell lung cancerKuan-Bing Chen, Ying Xuan, Wen-Jun Shi, et al.
Pageof 3